DIPENTUM 500 mg, tablet 60 tablets
Active ingredients: Olsalazine, Olsalazine sodium
Commercialized according to BDPM
Tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DIPENTUM 500 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 60 comprimé(s)
- Marketing authorisation holder
- ATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Oct 1999
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64457645CIP73394028CIP133400933940287Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OLSALAZINE SODIQUEcomprimé | 500,00 mg · un comprimé | SA |
| OLSALAZINE BASEcomprimé | 436,50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.